Clinical trial
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00002942 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00002942 |
|---|---|
| Title | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer |
| Official title | Randomized Phase III Trial of G-CSF Primed Autologous Bone Marrow Versus Peripheral Blood Progenitor Cells (PBPC) as Hematopoietic Support for High-Dose Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Therapy in Poor Prognosis Breast Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | autologous bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 136 |
| Start date | Jun 1, 1996 |
| Primary completion | Jan 1, 2000 |
| Completion | Dec 1, 2003 |
| First posted | Sep 3, 2004 |
| Last update posted | Aug 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: